Tetsu Hayashida
Chiyoda, 1008560, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
Individual monitoring for internal exposure of workers in FDNPS.
Journal: Annals of the ICRP
Published: May 13, 2026
Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: January 20, 2026
Proton-pump inhibitors and palbociclib or abemaciclib in endocrine-sensitive breast cancer treatment.
Journal: Scientific reports
Published: October 09, 2025
Exploring Breast Cancer Risk Management in HBOC Patients: Image Surveillance Versus Risk-reducing Surgery.
Journal: The Keio journal of medicine
Published: April 02, 2025
A retrospective multi-center cohort study investigating safety of sentinel lymph node biopsy for axillary staging in clinical T3-4c breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: March 27, 2025
Axillary surgery in patients with breast cancer with one to three positive micro- or macrometastases in the sentinel lymph nodes: an observational study.
Journal: Breast cancer (Tokyo, Japan)
Published: February 03, 2025
The Future of Breast Cancer Diagnosis in Japan with AI and Ultrasonography.
Journal: JMA journal
Published: July 20, 2024
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: May 24, 2024
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.
Journal: International journal of clinical oncology
Published: January 31, 2024
Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer.
Journal: The oncologist
Published: November 27, 2023
Last Updated: 09/26/2026